Form 6-K XTL BIOPHARMACEUTICALS For: Dec 01
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
XTL Biopharma (XTLB) Reports Q3 Breakeven Loss
December 1, 2015 8:33 AM ESTXTL Biopharma (NASDAQ: XTLB) reported Q3 EPS of $-0.00, versus $-0.00 reported last year.
For earnings history and earnings-related data on XTL Biopharma (XTLB) click here.
... More